Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Boron containing doai
Patent
1995-03-24
1997-06-17
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Boron containing doai
514 18, 514 19, 530331, 544 60, 544 69, 544229, 546 13, 548110, A61K 3169, C07F 502, C07F 504, C07K 5065
Patent
active
056397399
ABSTRACT:
The present invention relates generally to .alpha.-aminoboronic acids and corresponding peptide analogs of the formula (I): ##STR1## in which the .alpha.-carbon is substituted with an optionally functionalized imidazole containing alkyl group. These compounds are useful as inhibitors of trypsin-like serine protease enzymes, especially thrombin, Factor X and Factor VII.
REFERENCES:
patent: 4499082 (1985-02-01), Shenvi et al.
patent: 4537773 (1985-08-01), Shenvi
patent: 5106948 (1992-04-01), Kinder et al.
patent: 5169841 (1992-12-01), Kleeman et al.
patent: 5187157 (1993-02-01), Kettner et al.
patent: 5288707 (1994-02-01), Metternich
patent: 5332822 (1994-07-01), Misra
patent: 5444049 (1995-08-01), de Nanteuil et al.
patent: 5462964 (1995-10-01), Fevig et al.
patent: 5543526 (1996-08-01), Mallart et al.
Kettner et al, Journal of Biological Chemistry, 265, pp. 18289-18297 (190).
Cacciola Joseph
Dominguez Celia
Fevig John Matthew
Bernhardt Emily
The DuPont Merck Pharmaceutical Company
LandOfFree
Imidazole containing aminoboronic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole containing aminoboronic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole containing aminoboronic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2157859